Next |
home / stock / xene / xene message board
Subject | By | Source | When |
---|---|---|---|
MEAN $XENE @ it aGAIN | TheFinalCD | investorshub | 10/06/2021 4:20:22 PM |
I bought some yesterday at close (26) hopefully | LowFloatLopes | investorshub | 10/05/2021 11:07:45 AM |
$34 CLOSE= WOW | TheFinalCD | investorshub | 10/05/2021 12:51:00 AM |
Don't really care about the semantics just the | rynlrt | investorshub | 10/04/2021 11:12:14 PM |
$XENE Has $3.5M in debt | BottomBounce | investorshub | 10/04/2021 10:45:01 PM |
oh it will :D | stock1ace1 | investorshub | 10/04/2021 9:26:18 PM |
WOW the $250M offering didnt really affect | TheFinalCD | investorshub | 10/04/2021 9:25:44 PM |
Xenon Pharmaceuticals Inc. (Nasdaq: $XENE), a clinical stage | stock1ace1 | investorshub | 10/04/2021 8:57:22 PM |
Offering > Xenon Pharmaceuticals Inc. (Nasdaq: $XENE), a | stock1ace1 | investorshub | 10/04/2021 8:54:13 PM |
offering after hrs | stock1ace1 | investorshub | 10/04/2021 8:45:32 PM |
$33'S WOW | TheFinalCD | investorshub | 10/04/2021 8:14:52 PM |
If it breaks 30 it's gonna pop | rynlrt | investorshub | 10/04/2021 7:06:59 PM |
Let's run the 30's > | crudeoil24 | investorshub | 10/04/2021 5:05:02 PM |
YEHHHAAAAAAAA! | crudeoil24 | investorshub | 10/04/2021 4:59:08 PM |
$30.47 new highs | TheFinalCD | investorshub | 10/04/2021 4:55:03 PM |
William Blair Raises Price Target From $30 To | crudeoil24 | investorshub | 10/04/2021 3:46:46 PM |
500 shares to see where it goes | Marvy | investorshub | 10/04/2021 3:35:58 PM |
37M trading float > | crudeoil24 | investorshub | 10/04/2021 3:33:22 PM |
MEAN $XENE | TheFinalCD | investorshub | 10/04/2021 3:24:16 PM |
Not the flyest numbers. -83.4% Rev growth, -334.68% | make it happen | investorshub | 10/04/2021 12:28:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Xenon Pharmaceuticals Inc. Company Name:
XENE Stock Symbol:
NASDAQ Market:
Xenon Pharmaceuticals Inc. Website:
2024-05-15 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Phase 3 epilepsy program continues to progress with anticipated completion of patient enrollment in X-TOLE2 in late 2024 to early 2025 Successful “end-of-Phase 2” interactions with FDA in MDD; Phase 3 program on track to initiate in the second half of the year Azet...
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV....